Radiopharm Theranostics Limited (RADX)

CIK 0001949257 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
FY-2025
Latest FY-2025 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
—
Audit Information
—
Statements
Consolidated Statement of Profit Or Loss and Other Comprehensive Income
—
Consolidated Statement of Financial Position
—
Consolidated Statement of Changes In Equity
—
Consolidated Statement of Cash Flows
—
Notes
Capital Management
—
Cash Flow Information
—
Commitments
—
Contingent Consideration
—
Cybersecurity Risk Management and Strategy Disclosure
—
Equity
—
Events Occurring After The Reporting Year
—
Financial Assets and Financial Liabilities
—
Financial Risk Management
—
Income Tax Expense
—
Insider Trading Policies and Procedures
—
Interests In Other Entities
—
Loss Per Share
—
Material Estimates and Judgements
—
Non-financial Assets and Liabilities
—
Other Income and Expense Items
—
Parent Entity Financial Information
—
Related Party Transactions
—
Remuneration of Auditors
—
Revenue From Contract With Customers
—
Segment Information
—
Share-based Payments
—
Summary of Material Accounting Policies
—